Higashihara E - Search Results

1

[Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].

Okegawa T, Kato M, Miyata A, Murata A, Miura I, Yoneda T, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. Hinyokika Kiyo. 1999 Mar;45(3):175-8. Hinyokika Kiyo. 1999. PMID: 10331169 Free article. Japanese.

2

Significance of serum free prostate specific antigen in the screening of prostate cancer.

Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T. Higashihara E, et al. J Urol. 1996 Dec;156(6):1964-8. J Urol. 1996. PMID: 8911366 Review.

3

Significance of free prostate-specific antigen and gamma-seminoprotein in the screening of prostate cancer.

Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T. Higashihara E, et al. Prostate Suppl. 1996;7:40-7. doi: 10.1002/(sici)1097-0045(1996)7+<40::aid-pros6>3.0.co;2-n. Prostate Suppl. 1996. PMID: 8950363 Clinical Trial.

4

Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.

Okegawa T, Yoshioka J, Morita R, Nutahara K, Tsukada Y, Higashihara E. Okegawa T, et al. Among authors: higashihara e. Int J Urol. 1998 Jul;5(4):349-56. doi: 10.1111/j.1442-2042.1998.tb00365.x. Int J Urol. 1998. PMID: 9712443 Free article.

5

Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy.

Okegawa T, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. BJU Int. 1999 Jul;84(1):112-7. doi: 10.1046/j.1464-410x.1999.00076.x. BJU Int. 1999. PMID: 10444137

6

Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.

Okegawa T, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. J Urol. 2000 Apr;163(4):1183-8. J Urol. 2000. PMID: 10737491

7

The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.

Okegawa T, Kinjo M, Watanabe K, Noda H, Kato M, Miyata A, Murata A, Yoshii M, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. BJU Int. 2000 Apr;85(6):708-14. doi: 10.1046/j.1464-410x.2000.00602.x. BJU Int. 2000. PMID: 10759671

8

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.

Okegawa T, Noda H, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. Urology. 2000 May;55(5):700-4. doi: 10.1016/s0090-4295(99)00589-0. Urology. 2000. PMID: 10792084 Clinical Trial.

9

Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer.

Okegawa T, Noda H, Kato M, Miyata A, Nutahara K, Higashihara E. Okegawa T, et al. Among authors: higashihara e. Prostate. 2000 Aug 1;44(3):210-8. doi: 10.1002/1097-0045(20000801)44:3<210::aid-pros5>3.0.co;2-u. Prostate. 2000. PMID: 10906737

10

[Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].

Nutahara K, Higashihara E. Nutahara K, et al. Among authors: higashihara e. Nihon Rinsho. 2000 Jul;58 Suppl:95-8. Nihon Rinsho. 2000. PMID: 11022692 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters